1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Newly Diagnosed Secondary or High Risk AML: new trials by email Literature Review of Newly Diagnosed Secondary or High Risk AML trials Research Report on Newly Diagnosed Secondary or High Risk AML
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With CPX-351 for Patients Aged 60 to 75 Years With Secondary or High-risk Acute Myeloid Leukemia CPX-351 - Newly Diagnosed Secondary or High Risk AML | Phase 2 | Completed | PETHEMA Foundation | 59 | 2019-12-26 | 2026-06-25 |
CPX-351 (1)
Spain (1)
2018 (1)